Detalhe da pesquisa
1.
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
Pediatr Blood Cancer
; 66(5): e27657, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30724025
2.
Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies.
J Antimicrob Chemother
; 73(7): 1908-1916, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684147
3.
Current management of late onset neonatal bacterial sepsis in five European countries.
Eur J Pediatr
; 173(8): 997-1004, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24522326
4.
Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.
PLoS One
; 15(3): e0229380, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130261
5.
Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial.
Trials
; 12: 215, 2011 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21958494